Cargando…

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis

BACKGROUND: Despite advances in the treatment of rheumatoid arthritis (RA) and the wide range of therapies available, there is a percentage of patients whose treatment presents a challenge for clinicians due to lack of response to multiple biologic and target-specific disease-modifying antirheumatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Novella-Navarro, Marta, Benavent, Diego, Ruiz-Esquide, Virginia, Tornero, Carolina, Díaz-Almirón, Mariana, Chacur, Chafik Alejandro, Peiteado, Diana, Villalba, Alejandro, Sanmartí, Raimon, Plasencia-Rodríguez, Chamaida, Balsa, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549195/ https://www.ncbi.nlm.nih.gov/pubmed/36226311 http://dx.doi.org/10.1177/1759720X221124028

Ejemplares similares

Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2020)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
por: Novella-Navarro, Marta, et al.
Publicado: (2021)

Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization
por: Benavent, Diego, et al.
Publicado: (2021)

Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment
por: Novella -Navarro, Marta, et al.
Publicado: (2023)

Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
por: Benavent, Diego, et al.
Publicado: (2020)

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2022)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study
por: Bogas, Patricia, et al.
Publicado: (2021)

Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients
por: Jurado, Teresa, et al.
Publicado: (2017)

Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Effect of Infliximab Dose Increase in Rheumatoid Arthritis at Different Trough Concentrations: A Cohort Study in Clinical Practice Conditions
por: Plasencia, Chamaida, et al.
Publicado: (2015)

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
por: Cabrera-Villalba, Sonia, et al.
Publicado: (2017)

Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis
por: Arroyo-Villa, Irene, et al.
Publicado: (2014)

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity
por: Inciarte-Mundo, José, et al.
Publicado: (2016)

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission
por: Ramírez, Julio, et al.
Publicado: (2016)

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study
por: Inciarte-Mundo, José, et al.
Publicado: (2018)

Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment
por: Plasencia-Rodríguez, Chamaida, et al.
Publicado: (2023)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
por: Benavent, Diego, et al.
Publicado: (2023)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Monitoring chronic inflammatory musculoskeletal diseases mixing virtual and face-to-face assessments—Results of the digireuma study
por: Benavent, Diego, et al.
Publicado: (2022)

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
por: Gómez-Puerta, José A, et al.
Publicado: (2013)

Improved classification of rheumatoid arthritis with a score including anti-acetylated ornithine antibodies
por: Rodriguez-Martínez, Lorena, et al.
Publicado: (2020)

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
por: Sanmartí, Raimon, et al.
Publicado: (2023)

Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers
por: Ramírez, Julio, et al.
Publicado: (2014)

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2023)

Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients
por: Cordero, Oscar J., et al.
Publicado: (2022)

Healthcare-related impact of gout in hospitalized patients in Spain
por: Benavent, Diego, et al.
Publicado: (2021)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
por: Sanmartí, Raimon, et al.
Publicado: (2009)

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review
por: Navarro-Compán, Victoria, et al.
Publicado: (2017)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Clinical course, severity and mortality in a cohort of patients with COVID-19 with rheumatic diseases
por: Nuño, Laura, et al.
Publicado: (2020)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
por: Rodríguez-Martín, Eulalia, et al.
Publicado: (2020)

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis
por: Haro, Isabel, et al.
Publicado: (2022)

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sa5nbtc62h0df2h5kpch9sj3lk